Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Prostate Cancer

Free Subscription Articles published in Eur J Radiol Retrieve available abstracts of 56 articles: HTML format

Single Articles

February 2021
1. KLINGEBIEL M, Arsov C, Ullrich T, Quentin M, et al
   Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
   Eur J Radiol. 2021;137:109587.
   PubMed     Abstract available
   
   
   
2. ARITA Y, Yoshida S, Waseda Y, Takahara T, et al
   Diagnostic value of computed high b-value whole-body diffusion-weighted imaging for primary prostate cancer.
   Eur J Radiol. 2021;137:109581.
   PubMed     Abstract available
   
   
   January 2021
3. MORAWITZ J, Kirchner J, Lakes J, Bruckmann NM, et al
   PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications.
   Eur J Radiol. 2021;136:109556.
   PubMed     Abstract available
   
   
   
4. WANG X, Hielscher T, Radtke JP, Gortz M, et al
   Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer.
   Eur J Radiol. 2021;136:109538.
   PubMed     Abstract available
   
   
   November 2020
5. CHRISTOPHE C, Montagne S, Bourrelier S, Roupret M, et al
   Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350].
   Eur J Radiol. 2020 Nov 20:109417. doi: 10.1016/j.ejrad.2020.109417.
   PubMed    
   
   
   October 2020
6. CHRISTOPHE C, Montagne S, Bourrelier S, Roupret M, et al
   Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
   Eur J Radiol. 2020;132:109350.
   PubMed     Abstract available
   
   
   August 2020
7. BARRAL M, Jemal-Turki A, Beuvon F, Soyer P, et al
   Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
   Eur J Radiol. 2020;131:109230.
   PubMed     Abstract available
   
   
   July 2020
8. KLINGEBIEL M, Ullrich T, Quentin M, Bonekamp D, et al
   Advanced diffusion weighted imaging of the prostate: Comparison of readout-segmented multi-shot, parallel-transmit and single-shot echo-planar imaging.
   Eur J Radiol. 2020;130:109161.
   PubMed     Abstract available
   
   
   June 2020
9. WEI CG, Chen T, Zhang YY, Pan P, et al
   Erratum to "Biparameteric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels" [Eur. J. Radiol. 127 (2020) 108977].
   Eur J Radiol. 2020 Jun 21:109129. doi: 10.1016/j.ejrad.2020.109129.
   PubMed    
   
   
   
10. WANG R, Shen G, Yang R, Ma X, et al
    (68)Ga-PSMA PET/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: A meta-analysis.
    Eur J Radiol. 2020;130:109131.
    PubMed     Abstract available
    
    
    
11. LI Q, Duan Y, Baikpour M, Pierce TT, et al
    Magnetic resonance imaging/transrectal ultrasonography fusion guided seed placement in a phantom: Accuracy between 2-seed versus 1-seed strategies.
    Eur J Radiol. 2020;129:109126.
    PubMed     Abstract available
    
    
    
12. LEE CH
    PIRADS v2.1: Value of diffusion-weighted imaging for PIRADS scoring of transition zone lesions.
    Eur J Radiol. 2020;129:109117.
    PubMed    
    
    
    May 2020
13. STANZIONE A, Gambardella M, Cuocolo R, Ponsiglione A, et al
    Prostate MRI radiomics: A systematic review and radiomic quality score assessment.
    Eur J Radiol. 2020;129:109095.
    PubMed     Abstract available
    
    
    
14. MAHJOUB S, Baur ADJ, Lenk J, Lee CH, et al
    Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: Peripheral zone cancers are smaller and more predictable than transition zone tumors.
    Eur J Radiol. 2020;129:109071.
    PubMed     Abstract available
    
    
    April 2020
15. FALASCHI Z, Valenti M, Lanzo G, Attanasio S, et al
    Accuracy of ADC ratio in discriminating true and false positives in multiparametric prostatic MRI.
    Eur J Radiol. 2020;128:109024.
    PubMed     Abstract available
    
    
    
16. ZHANG W, Mao N, Wang Y, Xie H, et al
    A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
    Eur J Radiol. 2020;128:109020.
    PubMed     Abstract available
    
    
    
17. WEI CG, Chen T, Zhang YY, Pan P, et al
    Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with "gray zone" PSA levels.
    Eur J Radiol. 2020;127:108977.
    PubMed     Abstract available
    
    
    February 2020
18. CHEN Z, Xue Y, Zhang Z, Li W, et al
    The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Eur J Radiol. 2020;125:108865.
    PubMed     Abstract available
    
    
    October 2019
19. BECKER AS, Chaitanya K, Schawkat K, Muehlematter UJ, et al
    Variability of manual segmentation of the prostate in axial T2-weighted MRI: A multi-reader study.
    Eur J Radiol. 2019;121:108716.
    PubMed     Abstract available
    
    
    
20. TAMADA T, Kido A, Takeuchi M, Yamamoto A, et al
    Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Eur J Radiol. 2019;121:108704.
    PubMed     Abstract available
    
    
    September 2019
21. SAUER M, Tennstedt P, Berliner C, Well L, et al
    Predictors of short and long term urinary incontinence after radical prostatectomy in prostate MRI: Significance and reliability of standardized measurements.
    Eur J Radiol. 2019;120:108668.
    PubMed     Abstract available
    
    
    
22. CUOCOLO R, Stanzione A, Ponsiglione A, Verde F, et al
    Prostate MRI technical parameters standardization: A systematic review on adherence to PI-RADSv2 acquisition protocol.
    Eur J Radiol. 2019;120:108662.
    PubMed     Abstract available
    
    
    
23. SCHNEIDER AF, Stocker D, Hotker AM, Eberli D, et al
    Comparison of PSA-density of the transition zone and whole gland for risk stratification of men with suspected prostate cancer: A retrospective MRI-cohort study.
    Eur J Radiol. 2019;120:108660.
    PubMed     Abstract available
    
    
    
24. DING K, Yao Y, Gao Y, Lu X, et al
    Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Eur J Radiol. 2019;118:138-146.
    PubMed     Abstract available
    
    
    
25. CRISTEL G, Esposito A, Damascelli A, Briganti A, et al
    Can DCE-MRI reduce the number of PI-RADS v.2 false positive findings? Role of quantitative pharmacokinetic parameters in prostate lesions characterization.
    Eur J Radiol. 2019;118:51-57.
    PubMed     Abstract available
    
    
    July 2019
26. DANIEL M, Polanec SH, Wengert G, Clauser P, et al
    Intra- and inter-observer variability in dependence of T1-time correction for common dynamic contrast enhanced MRI parameters in prostate cancer patients.
    Eur J Radiol. 2019;116:27-33.
    PubMed     Abstract available
    
    
    
27. SCHAUDINN A, Gawlitza J, Mucha S, Linder N, et al
    Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Eur J Radiol. 2019;116:180-185.
    PubMed     Abstract available
    
    
    
28. CUOCOLO R, Stanzione A, Ponsiglione A, Romeo V, et al
    Clinically significant prostate cancer detection on MRI: A radiomic shape features study.
    Eur J Radiol. 2019;116:144-149.
    PubMed     Abstract available
    
    
    June 2019
29. MIN X, Li M, Dong D, Feng Z, et al
    Multi-parametric MRI-based radiomics signature for discriminating between clinically significant and insignificant prostate cancer: Cross-validation of a machine learning method.
    Eur J Radiol. 2019;115:16-21.
    PubMed     Abstract available
    
    
    May 2019
30. HERMIE I, Van Besien J, De Visschere P, Lumen N, et al
    Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.
    Eur J Radiol. 2019;114:92-98.
    PubMed     Abstract available
    
    
    
31. XU M, Fang M, Zou J, Yang S, et al
    Using biparametric MRI radiomics signature to differentiate between benign and malignant prostate lesions.
    Eur J Radiol. 2019;114:38-44.
    PubMed     Abstract available
    
    
    
32. LI W, Xin C, Zhang L, Dong A, et al
    Comparison of diagnostic performance between two prostate imaging reporting and data system versions: A systematic review.
    Eur J Radiol. 2019;114:111-119.
    PubMed     Abstract available
    
    
    April 2019
33. LI M, Huang Z, Yu H, Wang Y, et al
    Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis.
    Eur J Radiol. 2019;113:225-231.
    PubMed     Abstract available
    
    
    
34. LINDGREN BELAL S, Sadik M, Kaboteh R, Enqvist O, et al
    Deep learning for segmentation of 49 selected bones in CT scans: First step in automated PET/CT-based 3D quantification of skeletal metastases.
    Eur J Radiol. 2019;113:89-95.
    PubMed     Abstract available
    
    
    
35. ULLRICH T, Arsov C, Quentin M, Laqua N, et al
    Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients.
    Eur J Radiol. 2019;113:1-6.
    PubMed     Abstract available
    
    
    March 2019
36. ONAY A, Vural M, Armutlu A, Ozel Yildiz S, et al
    Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Eur J Radiol. 2019;112:192-199.
    PubMed     Abstract available
    
    
    January 2019
37. GHOLIZADEH N, Greer PB, Simpson J, Denham J, et al
    Characterization of prostate cancer using diffusion tensor imaging: A new perspective.
    Eur J Radiol. 2019;110:112-120.
    PubMed     Abstract available
    
    
    
38. AMINSHARIFI A, Gupta RT, Tsivian E, Sekar S, et al
    Reduced Core Targeted (RCT) biopsy: Combining multiparametric magnetic resonance imaging - transrectal ultrasound fusion targeted biopsy with laterally-directed sextant biopsies - An alternative template for prostate fusion biopsy.
    Eur J Radiol. 2019;110:7-13.
    PubMed     Abstract available
    
    
    
39. BARRETT T, Lawrence EM, Priest AN, Warren AY, et al
    Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis.
    Eur J Radiol. 2019;110:22-29.
    PubMed     Abstract available
    
    
    October 2018
40. MA S, Xu K, Xie H, Wang H, et al
    Diagnostic efficacy of b value (2000 s/mm(2)) diffusion-weighted imaging for prostate cancer: Comparison of a reduced field of view sequence and a conventional technique.
    Eur J Radiol. 2018;107:125-133.
    PubMed     Abstract available
    
    
    
41. SAUER M, Klene C, Kaul M, Quitzke A, et al
    Preoperative evaluation of pelvine lymph node metastasis in high risk prostate cancer with intravoxel incoherent motion (IVIM) MRI.
    Eur J Radiol. 2018;107:1-6.
    PubMed     Abstract available
    
    
    July 2018
42. CUOCOLO R, Stanzione A, Rusconi G, Petretta M, et al
    PSA-density does not improve bi-parametric prostate MR detection of prostate cancer in a biopsy naive patient population.
    Eur J Radiol. 2018;104:64-70.
    PubMed     Abstract available
    
    
    May 2018
43. AKIN-AKINTAYO O, Tade F, Mittal P, Moreno C, et al
    Prospective evaluation of fluciclovine ((18)F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients.
    Eur J Radiol. 2018;102:1-8.
    PubMed     Abstract available
    
    
    
44. CZARNIECKI M, Caglic I, Grist JT, Gill AB, et al
    Role of PROPELLER-DWI of the prostate in reducing distortion and artefact from total hip replacement metalwork.
    Eur J Radiol. 2018;102:213-219.
    PubMed     Abstract available
    
    
    April 2018
45. REISCHAUER C, Patzwahl R, Koh DM, Froehlich JM, et al
    Texture analysis of apparent diffusion coefficient maps for treatment response assessment in prostate cancer bone metastases-A pilot study.
    Eur J Radiol. 2018;101:184-190.
    PubMed     Abstract available
    
    
    
46. DI CAMPLI E, Delli Pizzi A, Seccia B, Cianci R, et al
    Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Eur J Radiol. 2018;101:17-23.
    PubMed     Abstract available
    
    
    February 2018
47. BENNDORF M, Waibel L, Kronig M, Jilg CA, et al
    Peripheral zone lesions of intermediary risk in multiparametric prostate MRI: Frequency and validation of the PI-RADSv2 risk stratification algorithm based on focal contrast enhancement.
    Eur J Radiol. 2018;99:62-67.
    PubMed     Abstract available
    
    
    January 2018
48. LI J, Weng Z, Xu H, Zhang Z, et al
    Support Vector Machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: A cross-validated study.
    Eur J Radiol. 2018;98:61-67.
    PubMed     Abstract available
    
    
    
49. SAUER M, Weinrich JM, Fraune C, Salomon G, et al
    Accuracy of multiparametric MR imaging with PI-RADS V2 assessment in detecting infiltration of the neurovascular bundles prior to prostatectomy.
    Eur J Radiol. 2018;98:187-192.
    PubMed     Abstract available
    
    
    
50. GRIVAS N, Hinnen K, de Jong J, Heemsbergen W, et al
    Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.
    Eur J Radiol. 2018;98:107-112.
    PubMed     Abstract available
    
    
    October 2017
51. HANSEN NL, Koo BC, Warren AY, Kastner C, et al
    Sub-differentiating equivocal PI-RADS-3 lesions in multiparametric magnetic resonance imaging of the prostate to improve cancer detection.
    Eur J Radiol. 2017;95:307-313.
    PubMed     Abstract available
    
    
    September 2017
52. BECKER AS, Cornelius A, Reiner CS, Stocker D, et al
    Direct comparison of PI-RADS version 2 and version 1 regarding interreader agreement and diagnostic accuracy for the detection of clinically significant prostate cancer.
    Eur J Radiol. 2017;94:58-63.
    PubMed     Abstract available
    
    
    August 2017
53. BENNDORF M, Hahn F, Kronig M, Jilg CA, et al
    Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
    Eur J Radiol. 2017;93:9-15.
    PubMed     Abstract available
    
    
    July 2017
54. KIM SH, Choi MS, Kim MJ, Kim YH, et al
    Role of semi-quantitative dynamic contrast-enhanced MR imaging in characterization and grading of prostate cancer.
    Eur J Radiol. 2017 Jul 6. pii: S0720-048X(17)30276.
    PubMed     Abstract available
    
    
    June 2017
55. PARK SY, Shin SJ, Jung DC, Cho NH, et al
    PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer.
    Eur J Radiol. 2017;91:22-28.
    PubMed     Abstract available
    
    
    May 2017
56. ULLRICH T, Quentin M, Oelers C, Dietzel F, et al
    Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality.
    Eur J Radiol. 2017;90:192-197.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: